IMMUNE CHECKPOINT INHIBITORS
Clinical trials for IMMUNE CHECKPOINT INHIBITORS explained in plain language.
Never miss a new study
Get alerted when new IMMUNE CHECKPOINT INHIBITORS trials appear
Sign up with your email to follow new studies for IMMUNE CHECKPOINT INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise in shrinking stomach tumors before surgery
Disease control Recruiting nowThis study tests whether adding the drug serplulimab to standard chemotherapy before surgery can better shrink advanced stomach or gastroesophageal junction cancer. About 116 adults will receive either the combination or chemo alone for three cycles before and after surgery. The …
Matched conditions: IMMUNE CHECKPOINT INHIBITORS
Phase: PHASE2 • Sponsor: Xijing Hospital • Aim: Disease control
Last updated May 17, 2026 05:21 UTC
-
New drug combo shows promise for aggressive bladder cancer
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug durvalumab to standard chemotherapy before bladder removal surgery is safe and effective for people with muscle-invasive bladder cancer. About 150 participants will receive the drug combination, then undergo surgery. The goal…
Matched conditions: IMMUNE CHECKPOINT INHIBITORS
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Immunotherapy side effects under the microscope: what patients really feel
Knowledge-focused Recruiting nowThis study aims to understand how severe and life-altering rheumatic side effects (like arthritis) can be for cancer patients treated with immunotherapy. Researchers will interview 20 English-speaking adults who have been diagnosed with these side effects by a rheumatologist. The…
Matched conditions: IMMUNE CHECKPOINT INHIBITORS
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
Could immune drugs help fight persistent brain viruses?
Knowledge-focused Recruiting nowThis study follows 66 people with chronic viral infections in the brain, like PML, to see if using immune checkpoint inhibitors can improve their long-term health. Researchers will track disability, brain scans, and virus levels over one year. The goal is to learn whether this ap…
Matched conditions: IMMUNE CHECKPOINT INHIBITORS
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated May 12, 2026 13:41 UTC